Long-term effects of treatments for childhood cancers

Jorge A. Alvarez, Rebecca E. Scully, Tracie L Miller, F. Daniel Armstrong, Louis S. Constine, Debra L. Friedman, Steven E Lipshultz

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: The late effects of current treatments for childhood cancer increase the risk of morbidity and mortality and diminish the quality of life in long-term survivors. We selectively review the negative late cardiac, endocrine, and neurological effects of childhood cancer and its treatments and comment on current research and recommendations for the care of long-term survivors of childhood cancer. RECENT FINDINGS: Progressive cardiotoxicity has been established. Late cardiac effects can be mitigated with the concomitant use of dexrazoxane with anthracycline. When radiotherapy is used multiple organ systems must be monitored for known late effects dependent on the location. Proper diet, physical activity, and obesity are topics that must be addressed in survivors. Late neurocognitive effects impact intelligence quotient, behavior, and achievement. Systematic follow-up with appropriate clinical screening and testing is important in diagnosing and potentially preventing late effects of cancer therapy. SUMMARY: The new paradigm for defining successful cancer therapy is the balance between oncologic efficacy and toxicity/late effects. The complexity of late effects necessitates a multidisciplinary approach to long-term care of these patients. The high frequency, delayed onset, and potential severity of late effects demand increased and lifelong monitoring of these individuals.

Original languageEnglish
Pages (from-to)23-31
Number of pages9
JournalCurrent Opinion in Pediatrics
Volume19
Issue number1
DOIs
StatePublished - Feb 1 2007

Fingerprint

Survivors
Neoplasms
Dexrazoxane
Therapeutics
Anthracyclines
Long-Term Care
Intelligence
Radiotherapy
Obesity
Quality of Life
Exercise
Diet
Morbidity
Mortality
Research
Cardiotoxicity

Keywords

  • Cardiology
  • Childhood cancer
  • Endocrinology
  • Long-term treatment effects
  • Neurocognition
  • Survivorship

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Alvarez, J. A., Scully, R. E., Miller, T. L., Daniel Armstrong, F., Constine, L. S., Friedman, D. L., & Lipshultz, S. E. (2007). Long-term effects of treatments for childhood cancers. Current Opinion in Pediatrics, 19(1), 23-31. https://doi.org/10.1097/MOP.0b013e328013c89e

Long-term effects of treatments for childhood cancers. / Alvarez, Jorge A.; Scully, Rebecca E.; Miller, Tracie L; Daniel Armstrong, F.; Constine, Louis S.; Friedman, Debra L.; Lipshultz, Steven E.

In: Current Opinion in Pediatrics, Vol. 19, No. 1, 01.02.2007, p. 23-31.

Research output: Contribution to journalArticle

Alvarez, JA, Scully, RE, Miller, TL, Daniel Armstrong, F, Constine, LS, Friedman, DL & Lipshultz, SE 2007, 'Long-term effects of treatments for childhood cancers', Current Opinion in Pediatrics, vol. 19, no. 1, pp. 23-31. https://doi.org/10.1097/MOP.0b013e328013c89e
Alvarez, Jorge A. ; Scully, Rebecca E. ; Miller, Tracie L ; Daniel Armstrong, F. ; Constine, Louis S. ; Friedman, Debra L. ; Lipshultz, Steven E. / Long-term effects of treatments for childhood cancers. In: Current Opinion in Pediatrics. 2007 ; Vol. 19, No. 1. pp. 23-31.
@article{dcde4e6308984c9db0591f497457e7e9,
title = "Long-term effects of treatments for childhood cancers",
abstract = "PURPOSE OF REVIEW: The late effects of current treatments for childhood cancer increase the risk of morbidity and mortality and diminish the quality of life in long-term survivors. We selectively review the negative late cardiac, endocrine, and neurological effects of childhood cancer and its treatments and comment on current research and recommendations for the care of long-term survivors of childhood cancer. RECENT FINDINGS: Progressive cardiotoxicity has been established. Late cardiac effects can be mitigated with the concomitant use of dexrazoxane with anthracycline. When radiotherapy is used multiple organ systems must be monitored for known late effects dependent on the location. Proper diet, physical activity, and obesity are topics that must be addressed in survivors. Late neurocognitive effects impact intelligence quotient, behavior, and achievement. Systematic follow-up with appropriate clinical screening and testing is important in diagnosing and potentially preventing late effects of cancer therapy. SUMMARY: The new paradigm for defining successful cancer therapy is the balance between oncologic efficacy and toxicity/late effects. The complexity of late effects necessitates a multidisciplinary approach to long-term care of these patients. The high frequency, delayed onset, and potential severity of late effects demand increased and lifelong monitoring of these individuals.",
keywords = "Cardiology, Childhood cancer, Endocrinology, Long-term treatment effects, Neurocognition, Survivorship",
author = "Alvarez, {Jorge A.} and Scully, {Rebecca E.} and Miller, {Tracie L} and {Daniel Armstrong}, F. and Constine, {Louis S.} and Friedman, {Debra L.} and Lipshultz, {Steven E}",
year = "2007",
month = "2",
day = "1",
doi = "10.1097/MOP.0b013e328013c89e",
language = "English",
volume = "19",
pages = "23--31",
journal = "Current Opinion in Pediatrics",
issn = "1040-8703",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Long-term effects of treatments for childhood cancers

AU - Alvarez, Jorge A.

AU - Scully, Rebecca E.

AU - Miller, Tracie L

AU - Daniel Armstrong, F.

AU - Constine, Louis S.

AU - Friedman, Debra L.

AU - Lipshultz, Steven E

PY - 2007/2/1

Y1 - 2007/2/1

N2 - PURPOSE OF REVIEW: The late effects of current treatments for childhood cancer increase the risk of morbidity and mortality and diminish the quality of life in long-term survivors. We selectively review the negative late cardiac, endocrine, and neurological effects of childhood cancer and its treatments and comment on current research and recommendations for the care of long-term survivors of childhood cancer. RECENT FINDINGS: Progressive cardiotoxicity has been established. Late cardiac effects can be mitigated with the concomitant use of dexrazoxane with anthracycline. When radiotherapy is used multiple organ systems must be monitored for known late effects dependent on the location. Proper diet, physical activity, and obesity are topics that must be addressed in survivors. Late neurocognitive effects impact intelligence quotient, behavior, and achievement. Systematic follow-up with appropriate clinical screening and testing is important in diagnosing and potentially preventing late effects of cancer therapy. SUMMARY: The new paradigm for defining successful cancer therapy is the balance between oncologic efficacy and toxicity/late effects. The complexity of late effects necessitates a multidisciplinary approach to long-term care of these patients. The high frequency, delayed onset, and potential severity of late effects demand increased and lifelong monitoring of these individuals.

AB - PURPOSE OF REVIEW: The late effects of current treatments for childhood cancer increase the risk of morbidity and mortality and diminish the quality of life in long-term survivors. We selectively review the negative late cardiac, endocrine, and neurological effects of childhood cancer and its treatments and comment on current research and recommendations for the care of long-term survivors of childhood cancer. RECENT FINDINGS: Progressive cardiotoxicity has been established. Late cardiac effects can be mitigated with the concomitant use of dexrazoxane with anthracycline. When radiotherapy is used multiple organ systems must be monitored for known late effects dependent on the location. Proper diet, physical activity, and obesity are topics that must be addressed in survivors. Late neurocognitive effects impact intelligence quotient, behavior, and achievement. Systematic follow-up with appropriate clinical screening and testing is important in diagnosing and potentially preventing late effects of cancer therapy. SUMMARY: The new paradigm for defining successful cancer therapy is the balance between oncologic efficacy and toxicity/late effects. The complexity of late effects necessitates a multidisciplinary approach to long-term care of these patients. The high frequency, delayed onset, and potential severity of late effects demand increased and lifelong monitoring of these individuals.

KW - Cardiology

KW - Childhood cancer

KW - Endocrinology

KW - Long-term treatment effects

KW - Neurocognition

KW - Survivorship

UR - http://www.scopus.com/inward/record.url?scp=33846304279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846304279&partnerID=8YFLogxK

U2 - 10.1097/MOP.0b013e328013c89e

DO - 10.1097/MOP.0b013e328013c89e

M3 - Article

C2 - 17224658

AN - SCOPUS:33846304279

VL - 19

SP - 23

EP - 31

JO - Current Opinion in Pediatrics

JF - Current Opinion in Pediatrics

SN - 1040-8703

IS - 1

ER -